Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients
Article in DARU Journal of Pharmaceutical Sciences (April 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in DARU Journal of Pharmaceutical Sciences (April 2024)
Article in Head & Neck (December 2023)
Article in The American Journal of Cardiology (September 2023)